USFDA approves Mirabegron extended-release tablets

The product will be manufactured at Lupin’s facility in Nagpur, the statement added.

200
USFDA Approval
USFDA Approval

Last Updated on October 15, 2024 by The Health Master

The US Food and Drug Administration (USFDA) has approved Lupin’s Abbreviated New Drug Application (ANDA), Mirabegron Extended-Release Tablets, 25 mg, and 50 mg.

This approval is to market a generic equivalent of Myrbetriq extended-release tablets, 25 mg, and 50 mg, of Astellas Pharma Global Development, according to a statement from Lupin.

The product will be manufactured at Lupin’s facility in Nagpur, the statement added.

USFDA gives nod for this generic non-steroidal anti-inflammatory drug

USFDA approves Intravenous therapy for hearing loss

USFDA approves Terlipressin for injection to treat Kidney function

USFDA gives tentative approval for Sugammadex Injection

USFDA gives approval for Lenalidomide capsules

USFDA gives final approval for Cariprazine capsules

State FDAs of these states to be strengthened soon

Drug recall: Acyclovir Sodium Injection recalled due to this reason

FDA J&K suspended licenses of Medicals Stores & Pharma Dealers

J & J appeals to Maharashtra FDA minister to revoke cancellation of license

IPGA Tamil Nadu Branch Celebrates World Pharmacists Day

Changing the Regulations for Class A Medical Devices and its Impact

Govt plan to ban Codeine based cough syrups opposed by Pharma companies

Cancer medicines may get cheaper

Pharmacists – The Doctors behind the screens

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news